Prosecution Insights
Last updated: April 19, 2026

Poseida Therapeutics Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18264782 GENETICALLY MODIFIED INDUCED PLURIPOTENT STEM CELLS AND METHODS OF USE THEREOF GOMEZ RODRIGUEZ, JULIO WASHINGTON 1637 Non-Final OA Aug 09, 2023
18351442 COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS CARTER, SANDRA DILLAHUNT 1674 Non-Final OA Jul 12, 2023
18051109 HYPERACTIVE PIGGYBAC TRANSPOSASES NOAKES, SUZANNE MARIE 1656 Non-Final OA Oct 31, 2022
17822240 COMPOSITIONS AND METHODS FOR DIRECTING PROTEINS TO SPECIFIC LOCI IN THE GENOME WEHBE, ANNE MARIE SABRINA 1634 Final Rejection Aug 25, 2022
16977547 CARTYRIN COMPOSITIONS AND METHODS FOR USE ALLEN, MICHAEL D 1671 Final Rejection Sep 02, 2020

Managing Poseida Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month